Virus-like antigen display for cancer vaccine development, what is the potential?-Reference-Cited by-同舟云学术

Virus-like antigen display for cancer vaccine development, what is the potential?

Published:2018-03-30 Issue:4 Volume:17 Page:285-288
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Sander Adam F.¹,Lollini Pier-Luigi²

Affiliation:

1. Centre for Medical Parasitology at the Department of Immunology and Microbiology and Department of Infectious Diseases, University of Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark

2. Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1455505

Reference29 articles.

1. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

2. Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

3. Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

4. The influence of virus structure on antibody responses and virus serotype formation

5. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine development: Current trends and technologies;Life Sciences;2024-01

2. Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy;International Journal of Molecular Sciences;2023-08-19

3. Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine;Biomedicines;2022-10-20

4. Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications;Research Journal of Pharmacy and Technology;2022-06-28

5. B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer;Immunology Letters;2021-11